Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

4.24
Delayed Data
As of Oct 20
 +0.10 / +2.42%
Today’s Change
2.06
Today|||52-Week Range
5.18
+66.93%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close4.14
Today’s open4.18
Day’s range4.06 - 4.24
Volume42,765
Average volume (3 months)89,127
Market cap$79.9M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-114.81%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.00

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd-0.12-5.08%
AEZSAEterna Zentaris Inc+0.02+0.99%
PRTOProteon Therapeutics...-0.05-2.17%
HTGMHTG Molecular Diagno...-0.01-0.44%
Data as of 3:59pm ET, 10/20/2017

Financials

Last reporting dateOctober 17, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$5.0M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating &
Medical Officer
Ralph Z. Kern
Corporate headquarters
Hackensack, New Jersey

Forecasts